Copyright©2018 CSIR-Institute of Genomics and Integrative Biology | VS Lab |
hsa_circ_0005986 | |||
Gene | PRDM2 | Organism | Human |
Genome Locus | chr1:14057494-14068652:+ | Build | hg19 |
Disease | Hepatocellular Carcinoma | ICD-10 | Liver cell carcinoma (C22.0) |
DBLink | Link to database | PMID | 28410211 |
Experimental Method | |||
Sample Type | TissueS HepG2, SMMC7721, Huh7, MHCC97L, MHCC97H, HCCLM3 Cell lines | Comparison | HCC tissues and paired adjacent nontumorous tissues |
Method for Estimation | Quantitative PCR | PCR Details | |
Primers (Experimented) | Forward GAAACTGGCTGCGATATGTG ReverseCACAGGCTCAGTAGTGTTCTTTAAA | Statistics | Fold Change : Downregulated,2.94 pvalue : p< 0.001 |
Citation | |||
Fu, L, Chen, Q, Yao, T, Li, T, Ying, S, Hu, Y, Guo, J (2017). Hsa_circ_0005986 inhibits carcinogenesis by acting as a miR-129-5p sponge and is used as a novel biomarker for hepatocellular carcinoma. Oncotarget, 8, 27:43878-43888. |